Publications by authors named "Timothy D Shafman"

Claim this Profile
P
Prediction of Distant Metastases After Stereotactic Body Radiation Therapy for Early Stage NSCLC: Development and External Validation of a Multi-Institutional Model.
Sarah J Gao, Lan Jin, Hugh W Meadows, Timothy D Shafman, Cary P Gross

J Thorac Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-institutional analysis of stereotactic body radiation therapy for operable early-stage non-small cell lung carcinoma.
Benjamin H Kann, Vivek Verma, John M Stahl, Rudi Ross, Arie P Dosoretz, Timothy D Shafman

Radiother Oncol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic body radiotherapy with adjuvant systemic therapy for early-stage non-small cell lung carcinoma: A multi-institutional analysis.
Benjamin H Kann, Joseph A Miccio, John M Stahl, Rudi Ross, Vivek Verma, Timothy D Shafman

Radiother Oncol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of Biologically Effective Dose and Radiation Treatment Schedule on Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.
John M Stahl, Rudi Ross, Eileen M Harder, Brandon R Mancini, Pamela R Soulos, Timothy D Shafman

Int J Radiat Oncol Biol Phys· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported quality of life after stereotactic body radiation therapy versus moderate hypofractionation for clinically localized prostate cancer.
Skyler Bryce Johnson, Pamela R Soulos, Timothy D Shafman, Constantine A Mantz, Arie P Dosoretz

Radiother Oncol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current status of immunotherapy and gene therapy for high-grade gliomas.
James C Marsh, Justin Goldfarb, Timothy D Shafman, Aidnag Z Diaz

Cancer Control· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The utility of non-axial treatment beam orientations for lower lobe lung cancers.
Brian P Quaranta, Shiva K Das, Timothy D Shafman, Kim L Light, Lawrence B Marks

J Appl Clin Med Phys· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the ability of the antiangiogenic and anticytokine agent thalidomide to modulate radiation-induced lung injury.
Mitchell S Anscher, Jennifer Garst, Lawrence B Marks, Nicole Larrier, Frank Dunphy, Timothy D Shafman

Int J Radiat Oncol Biol Phys· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination chemotherapy and radiation therapy for upper aerodigestive tract cancers.
Timothy D Shafman

Med Health R I· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges in defining radiation pneumonitis in patients with lung cancer.
Zafer Kocak, Elizabeth S Evans, Su-Min Zhou, Keith L Miller, Rodney J Folz, Timothy D Shafman

Int J Radiat Oncol Biol Phys· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Anatomically-correct" dosimetric parameters may be better predictors for esophageal toxicity than are traditional CT-based metrics.
Daniel Kahn, Sumin Zhou, Sung-Ja Ahn, Donna Hollis, Xiaoli Yu, Timothy D Shafman

Int J Radiat Oncol Biol Phys· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosimetric and clinical predictors for radiation-induced esophageal injury.
Sung-Ja Ahn, Daniel Kahn, Sumin Zhou, Xiaoli Yu, Donna Hollis, Timothy D Shafman

Int J Radiat Oncol Biol Phys· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bronchial stenosis: an underreported complication of high-dose external beam radiotherapy for lung cancer?
Keith L Miller, Timothy D Shafman, Mitchell S Anscher, Su-Min Zhou, Robert W Clough

Int J Radiat Oncol Biol Phys· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A practical approach to pulmonary risk assessment in the radiotherapy of lung cancer.
Keith L Miller, Timothy D Shafman, Lawrence B Marks

Semin Radiat Oncol· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of long-term complications after TFG-beta1-guided very-high-dose thoracic radiotherapy.
Mitchell S Anscher, Lawrence B Marks, Timothy D Shafman, Robert Clough, Hong Huang

Int J Radiat Oncol Biol Phys· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Routine use of approximately 60 Gy once-daily thoracic irradiation for patients with limited-stage small-cell lung cancer.
Keith L Miller, Lawrence B Marks, Gregory S Sibley, Robert W Clough, Jennifer L Garst, Timothy D Shafman

Int J Radiat Oncol Biol Phys· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of a 90Sr/90Y radiation source train stepping for intravascular brachytherapy.
Moyed M Miften, Shiva K Das, Timothy D Shafman, Lawrence B Marks

Med Phys· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Receiver operating characteristic curves to assess predictors of radiation-induced symptomatic lung injury.
Pehr A Lind, Lawrence B Marks, Donna Hollis, Ming Fan, Su-Min Zhou, Timothy D Shafman

Int J Radiat Oncol Biol Phys· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas.
David A Reardon, Gamal Akabani, R Edward Coleman, Allan H Friedman, Henry S Friedman, Timothy D Shafman

J Clin Oncol· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis